Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

A Challenging Case of IgG4-related Lung Disease: A Case Report
Mokahal, Ali El , Hussein, S., Farah, Wigdan

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A6094-A6094

10.1164/ajrccm.2025.211.abstracts.a6094 Get It

Abstract Introduction:IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by lymphoplasmacytic infiltrates that tend to affect various organs, leading to diverse clinical manifestations. While commonly linked to conditions like pancreatitis and sialadenitis, it can also impact the lungs, causing pulmonary masses, consolidations, or pneumonia. Key histopathological features include IgG4-positive plasma cells and storiform fibrosis, although these may not always be present. Case Presentation: We present a case of an 82-year-old male with a past medical history significant for pulmonary cryptococcal infection and a previous COVID-19 infection, who presented to our pulmonology clinic with fatigue for two months followed by an upper respiratory infection that did not respond to several rounds of antibiotics. A chest CT scan revealed bilateral consolidative airspace opacities and lymphadenopathy. Subsequent bronchoscopy with transbronchial biopsy and bronchoalveolar lavage (BAL) suggested a possible cryptococcal infection; however, his symptoms did not improve after a course of fluconazole. A follow-up PET-CT scan showed increased metabolic activity in the bilateral pulmonary consolidations, thoracic adenopathy, a possible right supraclavicular lymph node, and bilateral inguinal lymph nodes. He underwent a repeat bronchoscopy with EBUS-guided biopsy of the FDG-avid lymphadenopathy, and pathology results indicated granulomatous inflammation. He was evaluated by ophthalmology for uveitis and signs of retinal detachment on brain MRI, as well as nephrology for a progressive decline in kidney function. A renal biopsy showed numerous plasma cells staining for IgG and IgG4, along with storiform interstitial nephritis, consistent with IgG4-related interstitial nephritis. His autoimmune evaluation revealed elevated levels of ANA, double-stranded DNA, RNP antibodies, and various IgG subclasses, including IgG1, IgG3, and IgG4. Considering the biopsy results and the reduced suspicion of an infectious process, he was initiated on immunosuppression treatment with prednisone and rituximab for the IgG4-related disease which resulted in significant improvement in both the patient's symptoms and kidney function. Discussion:In conclusion, this case emphasizes the diagnostic challenges of IgG4-related pulmonary disease, largely due to the nonspecific nature of the respiratory manifestations. In our case, the diagnosis remained unclear despite the patient undergoing both transbronchial and EBUS-guided lymph node biopsies. This highlights the importance of maintaining a high clinical suspicion for this underdiagnosed condition as early treatment can lead to notable recovery.
Telomere Biology Disorder Presented With De Novo Pneumocystis Jirovecii Pneumonia
Asad, Dayab , Joudeh, Nagham, Reeve, M., Omar, Ahmad Afiq Irshad, Zamora, Ana, Azar, J., Asad, D., Omar, A., Si, L.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A6082-A6082

10.1164/ajrccm.2025.211.abstracts.a6082 Get It

Abstract Background Pneumocystis jirovecii pneumonia (PJP) is commonly seen in immunocompromised patients. Telomere biology disorder (TBD), which is a genetic disorder marked by mutations in telomere-maintenance genes, leading to shortened telomere, accelerated aging, and multi-systems effects including the pulmonary and immune systems. Idiopathic pulmonary fibrosis (IPF) is the most common pulmonary manifestation in TBD. Opportunistic infections, such as PJP, occurring de novo are rare in TBD, presenting unique diagnostic and therapeutic challenges. Case Presentation We present a female in her seventies with chronic dry cough and exertional dyspnea referred for evaluation of interstitial lung disease (ILD). Her family history revealed early-onset pulmonary fibrosis in her mother and sister. A year before the presentation, she developed acute hypoxic respiratory failure with bilateral pulmonary infiltrates. Bronchoalveolar lavage confirmed PJP despite no established immunosuppression. She received Bactrim and prednisone without clinical improvement. High-resolution chest CT revealed progressive infiltrates and fibrotic lung disease. Surgical lung biopsy showed organizing pneumonia, diffuse alveolar damage, and fibrosis, consistent with probable usual interstitial pneumonia (UIP). Ultimately, she developed rapidly progressive ILD. Further evaluation ruled out autoimmune and connective tissue disease. Telomere studies confirmed TBD, with her lymphocyte and granulocyte telomere lengths between the 1st and 10th percentiles. (figure1) Genetic testing is underway for familial pulmonary fibrosis. Discussion This case illustrates a rare presentation of PJP de novo in a patient with TBD, highlighting opportunistic infections risk in those patients without immunosuppression and before transplantation. TBD results in quantitative and qualitative T-cell immunodeficiency, reducing CD4+ T-cell count, predisposing to opportunistic infections, including PJP. TBD patients often experience a rapidly progressive course of ILD due to inherited telomere dysfunction causing limited regenerative capacity of Alveolar epithelial type 2 cells (AEC2s) exacerbated by environmental or age-related factors such as oxidative stress or smoking. Management requires a multidisciplinary approach with early genetic testing, antifibrotic therapies, and prophylactic treatments to prevent infections. This case underscores the importance of considering TBD in patients with opportunistic infections like PJP in the absence of traditional immunosuppressive risk factor and in patients with premature or progressive pulmonary fibrosis. Conclusion Telomere biology disorder can present with rapidly progressive ILD with atypical infections like PJP while on immunosuppression. To the best of our knowledge de novo PJP pneumonia in patient with TBD is unreported in the literature. High clinical suspicion, quantitative CD4 evaluation and consideration of PJP prophylaxis prevent an otherwise fatal outcome. Figure1:
A Rare Condition With an Uncommon Trigger: Acute Eosinophilic Pneumonia Caused by Progesterone Administration
Alaws, Hossny, Baig, Hassan , Baig, Hassan Z

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A6044-A6044

10.1164/ajrccm.2025.211.abstracts.a6044 Get It

Abstract Introduction: Acute Eosinophilic pneumonia (AEP) is an eosinophilic pulmonary condition defined by symptoms of less than or equal to 1 month's duration, pulmonary infiltrates on imaging, pulmonary eosinophilia of 25% or greater on bronchoalveolar lavage (BAL) cell count or eosinophilic pneumonia on lung biopsy, and absence of other eosinophilic pulmonary diseases. It can be associated with a multitude of exposures, including medications, inhalants as well as systemic conditions. We report a case of AEP associated with intramuscular (IM) progesterone administration. Case: A 36-year-old female presented to the emergency department with dyspnea on exertion, cough productive of yellow sputum, and subjective fever of two days’ duration. She had undergone in vitro fertilization using IM Progesterone as luteal phase support and experienced a miscarriage one week prior. She had a heart rate of 132 and required oxygen at 2 Liters per minute via nasal cannula to maintain her saturation at 92%. Her complete blood count showed an absolute eosinophil count of 1800 cells/uL. She underwent a computed tomography angiography scan of the chest, which was negative for a pulmonary embolism but showed diffuse bilateral peripheral ground-glass opacities as well as consolidations in both lung bases. She was empirically started on prednisone 40 mg per day. She later underwent a flexible bronchoscopy with BAL of the right middle lobe as well as transbronchial cryobiopsies of the right lung. The BAL cell differential showed 63% eosinophils confirming the diagnosis of AEP. Pathology revealed patchy organizing pneumonia with scattered eosinophils. Autoimmune workup was negative, including antineutrophil antibodies, Anti-myeloperoxidase, and anti-proteinase-3 antibodies. Infectious workup, including blood, sputum, and BAL cultures, was also negative. The patient dramatically improved with steroid administration. Her symptoms resolved, and she was discharged on room air with a 4-week prednisone taper. A follow-up chest x-ray revealed resolution of the infiltrates. Discussion: AEP is a rare condition. One epidemiological study estimated the incidence of AEP at 9.1/100,000 person-years in a population of United States military personnel. Given the lack of other inciting medications and negative autoimmune and infectious workup, IM progesterone administration was deemed the likely etiology of her presentation. There are four case reports of IM progesterone as a cause of AEP. This case represents a classic presentation of AEP with the secondary to progesterone administration and with symptoms resolving promptly with steroid administration.
Pneumothoraces and Paramediastinal Cysts – A Rare Case of Birt-Hogg-Dubé Syndrome
Gmehlin, C.G., Egan, Aoife M.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A5987-A5987

10.1164/ajrccm.2025.211.abstracts.a5987 Get It

Abstract Introduction: Birt-Hogg-Dube (BHD) is a rare autosomal dominant genetic disorder caused by mutations in the FLCN tumor suppressor gene. Clinically, BHD is characterized by development of cutaneous fibrofolliculomas/trichodiscomas, renal tumors, and pulmonary cysts, the latter which can result in recurrent, spontaneous pneumothoraces. We present a case of BHD in which diagnosis was delayed given absence of dermatologic and renal manifestations. Case Report: A 66-year-old female never smoker with a past medical history of left-sided breast cancer treated with lumpectomy and chemoradiation and osteoporosis presented for evaluation of recurrent pneumothoraces. Her first pneumothoraces occurred in her 20s-30s and required doxycycline pleurodesis (right side) and video-assisted thoracoscopic pleurodesis (left side). The most recent pneumothorax was in her 50s and resolved with chest tube placement. She reported repeated episodes of pneumonia which prompted pulmonary re-evaluation. A non-contrast CT chest was obtained which demonstrated middle and lower lobe predominant irregular thin-walled cystic changes with paramediastinal involvement. Pulmonary function testing revealed mild hyperinflation but otherwise no evidence of obstruction, restriction, or diffusion limitations (FEV1 113% predicted, FEV1/FVC of 0.72 predicted, FVC 109% predicted, TLC 108% predicted, DLCO 90% predicted). Immunoglobulins and alpha-1 antitrypsin were obtained and normal. A lung biopsy was discussed for definitive diagnosis but never performed. Upon presentation to our clinic, she reported no symptoms such as cough, shortness of breath, pleuritic chest pain, fevers, arthralgias, myalgias, rashes, dry mouth, or dry eyes. A broad differential was considered and a connective tissue disease cascade, VEGF-D testing, and SPEP/UPEP were sent and negative/normal. Given the distribution of cysts on her CT, BHD was considered, and she was referred to clinical genetics for germline testing which identified a heterozygous FLCN variant (c.837dup, p.Glu280Argfs[asterisk]12) consistent with BHD. Discussion: BHD is a rare and underdiagnosed cause of cystic lung disease as it has a broad range of clinical manifestations. Recognizing the disease without either renal or dermatologic manifestations as in our patient can be challenging and requires a high degree of suspicion. Clues to the diagnosis include a family history of spontaneous pneumothorax, which can be highly predictive of BHD as it is the most common cause of hereditary pneumothorax. Definitive diagnosis of BHD depends on a combination of clinical features and germline testing for mutations in the FLCN gene.
A Case of Refractory, Forme Fruste Non-severe Eosinophilic Granulomatosis With Polyangiitis
Karanam, V., Chetram, Deandra , Kumar, N.R.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A5945-A5945

10.1164/ajrccm.2025.211.abstracts.a5945 Get It

Abstract Introduction EGPA is diagnosed clinically in patients with asthma, rhinosinusitis, and eosinophilia with end-organ involvement including neuropathy, lung infiltrates, cardiomyopathy, or kidney, gastrointestinal, or skin involvement. The five-factor score (FFS) differentiates non-severe (FFS = 0) and severe (FFS > 0) EGPA. Forme fruste, or partially treated, EGPA occurs when presumed severe eosinophilic asthma is treated with corticosteroids that can mask end organ damage typical of EGPA. We present a case of forme fruste non-severe EGPA that failed established treatments for non-severe and severe EGPA. Case Presentation This is a 38-year-old female presenting to the pulmonology clinic with three years of cough, dyspnea, wheezing, rhinorrhea, and chest heaviness. She was initially given prednisone for adult-onset asthma with improvement but was unable to taper due to symptom recrudescence on doses lower than 20 milligrams. Allergic bronchopulmonary aspergillosis testing was negative, fractional exhaled nitric oxide was elevated, pulmonary function testing showed moderate airway obstruction, and absolute eosinophil count was 11x10^3/microliter despite prednisone use. Chest computed tomography (CT) showed mild bronchial wall thickening. She was given benralizumab followed by mepolizumab, inhaled corticosteroid with a long-acting beta agonist, cetirizine, nasal budesonide, and two cycles of rituximab for possible EGPA at an outside hospital. At the current evaluation, Chest CT showed multiple nodules, patchy ground glass opacities, and bronchial wall thickening. CT sinuses showed paranasal sinus mucosal thickening with sinus outlet obstruction and nasal endoscopy showed polyps. Anti-neutrophil cytoplasmic antibody was negative, urinalysis showed mild hematuria, and bronchoalveolar lavage was negative for infection. Bone marrow did not suggest neoplasm and hematology workup did not identify other causes of hypereosinophilia. EGPA was considered highest on the differential. She was offered sinus surgery and lung biopsy for enrollment in refractory EGPA trials, but no further medical therapy was identified. Discussion This case shows the importance of recognizing potential forme fruste EGPA rather than asthma refractory to systemic glucocorticoids. Early suspicion is crucial to initiation of the proper regimen. Non-severe EGPA warrants treatment with corticosteroids and mepolizumab. Azathioprine and cyclophosphamide have demonstrated a comparable benefit in relapsing non-severe EGPA after steroid treatment, but in a single low power study. In our patient, who was refractory to glucocorticoids with mepolizumab and rituximab, there is no strong data suggesting further treatment not involving high dose steroids. In her case, chronic steroid use led to morbid obesity and obstructive sleep apnea, highlighting the importance of further research in non-severe EGPA treatment.
Rheumatoid Arthritis Pleural Lung Disease Mimicking Empyema
Asad, Dayab , Joudeh, N., McNierney, Dakota , D’Cunha, Jonathan, Sakata, Kenneth K. , Azar, J., Asad, D., Joudeh, N., Nagaraja, Vivek

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A5936-A5936

10.1164/ajrccm.2025.211.abstracts.a5936 Get It

Abstract Introduction Rheumatoid arthritis (RA) is a systemic autoimmune rheumatic disease (SARD) primarily associated with articular involvement, but is often associated with lung involvement, sometimes preceding articular symptoms. Common pulmonary manifestations include interstitial lung disease (ILD), airway, and serosal involvement. RA-related pleural disease can mimic empyema due to the pleural fluid's green, pus-like appearance, exudative nature, low pH, markedly low glucose, and elevated lactate dehydrogenase (LDH) levels. Empyema sometimes yields negative cultures which can accentuate the diagnostic challenge in such cases. This report presents a patient with RA-related pleural lung disease who was referred to our hospital with trapped lung presumed to be secondary to empyema in the setting of pleural-based pulmonary abscess. Case Report A 66-year-old female with a 22-year history of RA presented with recurrent right-sided pleural effusions and progressive dyspnea over three years. Her initial presentation in 2022 involved a large right-sided pleural effusion, suspected to result from a ruptured pleural-based pulmonary abscess that led to empyema and subsequently a trapped lung. Pleural fluid analysis showed elevated LDH (1364 U/L), low glucose (45 mg/dL), high cholesterol (121 mg/dL), and low triglycerides (79 mg/dL). Due to refractory exudative effusion and a comprehensive negative infectious evaluation (bacterial, mycobacterial, and fungal cultures), RA-related pleural disease was suspected. The patient underwent video-assisted thoracoscopic surgery (VATS), which revealed pleural-based rheumatoid nodules and pleural thickening. (figure1) Lung and pleural biopsies confirmed RA-associated fibrinous pleuritis, RA-associated follicular bronchiolitis, and usual interstitial pneumonitis. Given the complexity of the infection, a thoracotomy with decortication and pleurectomy was planned and conducted in stages. Immunosuppressive regimen was switched from leflunomide to rituximab. Discussion This case underscores the diagnostic complexity in distinguishing RA-associated pleural effusion from empyema. Features such as pleural nodularity resembling a pulmonary abscess, unilateral exudative effusion, grossly purulent pleural fluid, low pH and glucose, and elevated LDH levels led to an initial misdiagnosis of empyema. Characteristic pleural fluid, along with persistent negative cultures and absence of sepsis pointed towards RA-related pleural disease. VATS and biopsy were instrumental in establishing the final diagnosis through characteristic histopathological findings of RA-associated pleural, parenchymal and airway involvement. Conclusion For RA patients with pleural effusion suggestive of empyema, especially in the context of negative cultures and no signs of sepsis, RA-related pleural disease should be a consideration. Early recognition and timely immunosuppressive therapy escalation can prevent complications such as trapped lungs and reduce the necessity for extensive surgical interventions. Figure1:
A Fatal Turn: Hemophagocytic Lymphohistiocytosis in a Liver Transplant Patient Triggering Refractory Multiorgan Failure
Sen, Ayan , Rajesh, S.T., Li, S., Chen, Jingyu

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A5913-A5913

10.1164/ajrccm.2025.211.abstracts.a5913 Get It

Abstract Hemophagocytic lymphohistiocytosis (HLH) is a rare but critical hyperinflammatory condition that affects around 1.5% of liver transplant patients, with mortality rates reaching up to 33%. This syndrome is characterized by intense, dysregulated activation of macrophages and T-cells, sparking a cytokine surge that leads to severe systemic inflammation and rapid organ failure. Prompt identification and early management are crucial to improve outcomes. Case Presentation: A 61-year-old man with Hepatitis C-induced end-stage liver disease (MELD score 20) underwent a deceased-donor liver transplant. Postoperative complications included atrial fibrillation, stress cardiomyopathy, and a right-sided pleural effusion treated with thoracentesis and extended course of antibiotics. Two weeks later, he presented with fever, hypotension, and nausea, prompting the initiation of IV Zosyn, Vancomycin and Posaconazole. Despite fluid resuscitation, he became hemodynamically unstable, necessitating ICU transfer for vasopressor support. While in the ICU, his condition worsened, with increased fever, tachycardia, anuria and hypoxic respiratory failure that required intubation and continuous renal replacement therapy. Marked hyperferritinemia (ferritin 62,000 µg/L) and hypofibrinogenemia (91 mg/dL) raised suspicion for HLH, with an H score of 244. Comprehensive infectious workup ruled out CMV, EBV, HSV, and other pathogens. Bone marrow biopsy confirmed hemophagocytosis (Figure 1), and flow cytometry ruled out malignant infiltration. Given the strong suspicion for HLH and no identifiable infectious trigger, he was initiated on Dexamethasone, Etoposide, and Ruxolitinib, which lowered ferritin levels and improved vasopressor requirements. However, mentation declined, and imaging revealed a right frontal subarachnoid hemorrhage, likely from disseminated intravascular coagulation, precluding surgical intervention. Despite transient improvement, he developed ventilator associated pneumonia secondary to Stenotrophomonas infections and vancomycin-sensitive Enterococcus bacteremia, leading to refractory hypoxemia. After family and multi-disciplinary team discussions, care was withdrawn. Discussion: HLH remains an exceedingly rare, rapidly fatal syndrome in liver transplant recipients, with only 11 cases documented. Early recognition of HLH can be challenging, as its features, such as fever, cytopenias, and organ dysfunction, overlap with common post-transplant complications, which can delay diagnosis. HLH can be differentiated into primary (genetic) and secondary (acquired) forms, with the latter more common among adults, often triggered by infection, malignancies and autoimmune disorders. Immunosuppressants may inadvertently modulate HLH risk by tempering macrophage and T-cell activation, yet, paradoxically, also predisposing patients to secondary triggers. Clinicians should maintain vigilance for HLH in post-transplant patients with unexplained systemic inflammation, as early intervention is critical, often with Etoposide based regimens to modulate hypercytokinemia, though prognosis remains guarded due to multiorgan failure.
Correct Answer Was All The Above: A Case of Hemophagocytic Lymphohistiocytosis in the Intensive Care Unit
Braun, Chris, Zheng, C.Z.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A5892-A5892

10.1164/ajrccm.2025.211.abstracts.a5892 Get It

Abstract Introduction: Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of aggressive inflammation and immune system activation. Its diagnosis is often hindered by its clinical overlap with sepsis, multiorgan failure, and other severe diseases common in the intensive care unit. We present a case of HLH diagnosed in the setting of multiple confounding conditions. Case Presentation: 24-year-old Caucasian male with common variable immunodeficiency presented to local hospital after a week of diffuse swelling and shortness of breath, initially found to be hypoxemic, hypoglycemic, hypovolemic, and febrile to 105°F. He was treated for septic shock, requiring norepinephrine, vasopressin, angiotensin, and stress dose hydrocortisone to maintain perfusion pressures. For work of breathing, he failed noninvasive ventilation and was intubated. Initial labs showed shock liver, acute kidney injury with severe metabolic acidosis, and MSSA bacteremia without endocarditis on transesophageal echocardiogram. He met HLH diagnostic criteria with high fever and ferritin 44,838 ng/mL; other inflammatory markers were not tested. Over two weeks the patient developed significant left lower extremity soft tissue infection concerning for Staphylococcus toxic shock syndrome, cholecystitis with cholecystostomy tube placement, hemorrhagic bullae on all limbs, left thigh hematoma, and new liver lesion that underwent biopsy complicated by significant bleeding requiring interventional radiology embolization. After transfer to our institution, he remained on fluctuating doses of norepinephrine with recurring fevers despite broad spectrum antibiotic and antifungal coverage. Repeat blood cultures were negative, MRI negative for osteomyelitis, pan-CT negative for other occult sources of infection, broad laboratory workup negative for atypical infections or antibodies related to rheumatologic diseases. At this point, he fulfilled HLH criteria given high fever, anemia and thrombocytopenia, splenomegaly, triglyceride 417 mg/dL, ferritin 1,953 ng/mL, and soluble IL-2 receptor >4,000 pg/mL. A multidisciplinary decision was made to start methylprednisone. Patient's fever and hemodynamic instability quickly resolved. He was then transitioned to anakinra with downtrend in his inflammatory markers. Discussion: HLH syndrome is often a delayed diagnosis as clinical manifestations mimic infections, can be triggered by such infections, or mimic other diseases in which a robust inflammatory response occurs. HLH laboratory findings are nonspecific or can have long turnaround time. Even its namesake of “hemophagocytosis” is not pathognomic for the disease. It is only in the case of excessive pathologic immune system activation, i.e. HLH syndrome, that immunosuppression is beneficial. Diagnosing HLH requires a curious clinical mind while treating concomitant urgent conditions, to avoid the “tunnel vision” of the often-cited occam's razor.
Amiodarone Lung Toxicity Leading to Acute Respiratory Distress Syndrome in Patient With High-Risk Factors
Khan, Imran Ali , Khan, I.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A5858-A5858

10.1164/ajrccm.2025.211.abstracts.a5858 Get It

Abstract Amiodarone is a commonly used class III antiarrhythmic medication with a rare but well-known adverse effect of pulmonary toxicity. This case illustrates the importance of knowing the risk factors for the development of amiodarone-related lung toxicity, particularly in patients with pre-existing lung disease. Additionally, intensivists must remain mindful of non-infectious causes of ARDS, including acute medication-related lung toxicity. A 73-year-old man was admitted to the Medical Intensive Care Unit (MICU) for worsening hypoxic respiratory failure and progressive pulmonary infiltrates. He has a past medical history of vocal cord malignancy, lung cancer s/p left upper lobe lobectomy and had a left mainstem bronchus stent placed a month prior to presentation. Three weeks before coming to our ICU, the patient was being treated in the outpatient setting for pneumonia post stent placement and was started on rate controlling agents for newly diagnosed atrial fibrillation with rapid ventricular rate. He was ultimately loaded with amiodarone and switched to maintenance for rhythm control. During his stay in the MICU, he underwent a bronchoscopy with bronchoalveolar lavage (BAL), ECHO and repeat CT chest imaging to further investigate his hypoxemia. He was empirically being treated with vancomycin and meropenem. His chest CT compared to one month prior had developed diffuse ground glass opacities and his BAL was limited and unrevealing. He ultimately had progression of disease and was transitioned to comfort care. Amiodarone lung toxicity is a diagnosis of exclusion and presents as interstitial lung disease. A lung biopsy with histopathology is the gold standard for diagnosis and would show foamy laden macrophages. BAL findings include elevated cellular count with 50% of the cases showing eosinophilia. Amiodarone can have an acute, subacute and chronic presentation, with acute being the more aggressive subtype. A double-blind controlled study concluded that the incidence of severe lung fibrosis was 1.2% in doses ranging from 300-800mg compared to < 200mg daily [1] Another retrospective study in Japan found that there is an association with higher incidence of amiodarone induced lung toxicity in age greater than 60. [2] This case highlights a patient presenting with worsening hypoxic respiratory failure, and CT changes, shortly after receiving a second loading dose of amiodarone for atrial fibrillation. He continued to decompensate despite being on appropriate antibiotics and lack of improvement with diuretics. His chest CT was revealing new bilateral ground glass opacities with restrictive physiology on ventilator mechanics, and other causes were ruled out.
Surreptitious Shock: An Uncommon Etiology of Obstructive Shock Following Out-of-Hospital Cardiac Arrest
Phillips, Ana Maria Faísca , Egan, Aoife M. , Phillips, A.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A5811-A5811

10.1164/ajrccm.2025.211.abstracts.a5811 Get It

Abstract Obstructive shock is rare, occurring in 2% of patients admitted to the intensive care unit (ICU) with shock. Understanding the unique pathophysiology of obstructive shock can aid in resuscitation efforts and significantly impact patient outcomes. Our goal is to expand the current understanding of possible shock etiologies and the treatment of obstructive shock. We present a case of an 88-year-old woman presenting to the ICU following an out-of-hospital cardiac arrest. Family found her unresponsive, called EMS, and started CPR. Upon EMS arrival, she had a pulse; the rhythm was identified as atrial fibrillation. She was cardioverted and transferred to the emergency room. Upon admission, she was intubated and sedated but hemodynamically stable. Shortly after arrival, she developed refractory shock requiring volume resuscitation and rapid titration of three vasoactive medications. She intermittently responded to volume but quickly developed recurrent shock following infusion completion. Bedside ultrasound showed collapse of the right atrium with a pericardial effusion and hyperechoic mobile mass within the pericardial space. Cardiology was called to the bedside for further evaluation of possible cardiac tamponade. There was lack of consensus regarding need for pericardiocentesis. Therefore, further chest imaging was ordered. CTA chest was negative for pulmonary emboli but showed a large hematoma in the anterior mediastinum with active bleeding. Formal echocardiogram confirmed a large extracardiac mass with extrinsic compression of the right atrium as well as a small-moderate circumferential pericardial effusion without obvious features of tamponade. She underwent an urgent IR angiogram with embolization of the internal mammary artery and placement of a 14F locking loop pigtail catheter into the anterior mediastinal hematoma felt to be contained within a known 3.5 cm benign cystic lesion. She experienced significant hemodynamic improvement following embolization and drain placement. The etiology of her presumed PEA arrest remained unclear, though it was concluded that the obstructive shock was due to the anterior mediastinal hematoma, a consequence of CPR. In this case we highlight the risk of arterial hemorrhage following resuscitation for cardiac arrest and the role it can play in the development of obstructive shock. There have been some documented cases of pericardial bleeding and the development of cardiac tamponade but limited case reports regarding arterial hemorrhage following CPR. Quickly identifying extracardiac compression allowed for appropriate and rapid IR embolization which led to clinical improvement in our patient.